Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
1.840
+0.050 (2.79%)
At close: Jan 30, 2025, 4:00 PM
1.801
-0.039 (-2.14%)
After-hours: Jan 30, 2025, 6:02 PM EST
RVPH Employees
Reviva Pharmaceuticals Holdings had 15 employees as of December 31, 2023. The number of employees increased by 5 or 50.00% compared to the previous year.
Employees
15
Change (1Y)
5
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
-$2,200,973
Market Cap
85.71M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 15 | 5 | 50.00% |
| Dec 31, 2022 | 10 | 5 | 100.00% |
| Dec 31, 2021 | 5 | 0 | - |
| Dec 31, 2020 | 5 | 1 | 25.00% |
| Dec 31, 2019 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
RVPH News
- 10 hours ago - Reviva to Participate in the 2025 BIO CEO & Investor Conference - GlobeNewsWire
- 23 days ago - Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit - GlobeNewsWire
- 6 weeks ago - Reviva Announces Proposed Public Offering - GlobeNewsWire
- 7 weeks ago - Reviva Pharmaceuticals: Upcoming Events May Generate Excitement, But Cash Is Low - Seeking Alpha
- 2 months ago - Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 3 months ago - Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024 - GlobeNewsWire
- 3 months ago - Reviva to Participate in the UBS Global Healthcare Conference - GlobeNewsWire
- 4 months ago - Reviva to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire